The Cooper Companies, Inc. (COO)
USD 92.39
(-2.22%)
USD 92.39
(-2.22%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.59 Billion USD | 8.61% |
| 2022 | 3.3 Billion USD | 13.2% |
| 2021 | 2.92 Billion USD | 20.22% |
| 2020 | 2.43 Billion USD | -8.39% |
| 2019 | 2.65 Billion USD | 4.76% |
| 2018 | 2.53 Billion USD | 18.41% |
| 2017 | 2.13 Billion USD | 8.75% |
| 2016 | 1.96 Billion USD | 9.45% |
| 2015 | 1.79 Billion USD | 4.62% |
| 2014 | 1.71 Billion USD | 8.19% |
| 2013 | 1.58 Billion USD | 9.87% |
| 2012 | 1.44 Billion USD | 8.59% |
| 2011 | 1.33 Billion USD | 14.87% |
| 2010 | 1.15 Billion USD | 7.23% |
| 2009 | 1.08 Billion USD | 1.62% |
| 2008 | 1.06 Billion USD | 11.84% |
| 2007 | 950.64 Million USD | 10.67% |
| 2006 | 858.96 Million USD | 6.49% |
| 2005 | 806.61 Million USD | 64.56% |
| 2004 | 490.17 Million USD | 19.04% |
| 2003 | 411.79 Million USD | 30.6% |
| 2002 | 315.3 Million USD | 34.42% |
| 2001 | 234.57 Million USD | 18.88% |
| 2000 | 197.31 Million USD | 19.37% |
| 1999 | 165.3 Million USD | 12.3% |
| 1998 | 147.2 Million USD | 4.03% |
| 1997 | 141.5 Million USD | 29.7% |
| 1996 | 109.1 Million USD | 12.36% |
| 1995 | 97.1 Million USD | 1.57% |
| 1994 | 95.6 Million USD | 3.13% |
| 1993 | 92.7 Million USD | 46.45% |
| 1992 | 63.3 Million USD | 78.31% |
| 1991 | 35.5 Million USD | -26.35% |
| 1990 | 48.2 Million USD | -8.71% |
| 1989 | 52.8 Million USD | -91.36% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1 Billion USD | 6.39% |
| 2024 Q2 | 942.6 Million USD | 1.18% |
| 2024 Q1 | 931.6 Million USD | 0.49% |
| 2023 Q4 | 927.1 Million USD | -0.33% |
| 2023 Q2 | 877.4 Million USD | 2.2% |
| 2023 Q3 | 930.2 Million USD | 6.02% |
| 2023 Q1 | 858.5 Million USD | 1.23% |
| 2023 FY | 3.59 Billion USD | 8.61% |
| 2022 Q3 | 843.4 Million USD | 1.64% |
| 2022 Q2 | 829.8 Million USD | 5.41% |
| 2022 Q4 | 848.1 Million USD | 0.56% |
| 2022 FY | 3.3 Billion USD | 13.2% |
| 2022 Q1 | 787.2 Million USD | 3.7% |
| 2021 Q1 | 680.5 Million USD | -0.16% |
| 2021 Q3 | 763.4 Million USD | 6.1% |
| 2021 Q4 | 759.1 Million USD | -0.56% |
| 2021 Q2 | 719.5 Million USD | 5.73% |
| 2021 FY | 2.92 Billion USD | 20.22% |
| 2020 FY | 2.43 Billion USD | -8.39% |
| 2020 Q1 | 646.2 Million USD | -6.56% |
| 2020 Q3 | 578.2 Million USD | 10.15% |
| 2020 Q4 | 681.6 Million USD | 17.88% |
| 2020 Q2 | 524.9 Million USD | -18.77% |
| 2019 Q4 | 691.6 Million USD | 1.8% |
| 2019 FY | 2.65 Billion USD | 4.76% |
| 2019 Q1 | 628.1 Million USD | -3.59% |
| 2019 Q2 | 654.3 Million USD | 4.17% |
| 2019 Q3 | 679.4 Million USD | 3.84% |
| 2018 Q3 | 660 Million USD | 4.55% |
| 2018 Q2 | 631.3 Million USD | 7.0% |
| 2018 Q1 | 590 Million USD | 5.08% |
| 2018 FY | 2.53 Billion USD | 18.41% |
| 2018 Q4 | 651.5 Million USD | -1.29% |
| 2017 Q3 | 556 Million USD | 6.43% |
| 2017 FY | 2.13 Billion USD | 8.75% |
| 2017 Q4 | 561.5 Million USD | 0.99% |
| 2017 Q1 | 499.1 Million USD | -3.77% |
| 2017 Q2 | 522.4 Million USD | 4.67% |
| 2016 Q3 | 514.72 Million USD | 6.39% |
| 2016 FY | 1.96 Billion USD | 9.45% |
| 2016 Q4 | 518.65 Million USD | 0.76% |
| 2016 Q1 | 449.64 Million USD | -1.29% |
| 2016 Q2 | 483.79 Million USD | 7.6% |
| 2015 Q3 | 461.67 Million USD | 6.21% |
| 2015 FY | 1.79 Billion USD | 4.62% |
| 2015 Q4 | 455.53 Million USD | -1.33% |
| 2015 Q2 | 434.67 Million USD | -2.36% |
| 2015 Q1 | 445.17 Million USD | -4.88% |
| 2014 Q2 | 412.31 Million USD | 1.81% |
| 2014 Q4 | 467.99 Million USD | 8.21% |
| 2014 Q1 | 404.98 Million USD | -1.67% |
| 2014 FY | 1.71 Billion USD | 8.19% |
| 2014 Q3 | 432.48 Million USD | 4.89% |
| 2013 Q3 | 411.99 Million USD | 7.28% |
| 2013 Q4 | 411.85 Million USD | -0.03% |
| 2013 Q1 | 379.83 Million USD | -4.15% |
| 2013 Q2 | 384.04 Million USD | 1.11% |
| 2013 FY | 1.58 Billion USD | 9.87% |
| 2012 Q1 | 326.06 Million USD | -9.66% |
| 2012 FY | 1.44 Billion USD | 8.59% |
| 2012 Q4 | 396.3 Million USD | 4.79% |
| 2012 Q3 | 378.18 Million USD | 9.75% |
| 2012 Q2 | 344.58 Million USD | 5.68% |
| 2011 Q3 | 351.39 Million USD | 8.02% |
| 2011 FY | 1.33 Billion USD | 14.87% |
| 2011 Q4 | 360.9 Million USD | 2.71% |
| 2011 Q2 | 325.3 Million USD | 10.94% |
| 2011 Q1 | 293.22 Million USD | -6.42% |
| 2010 FY | 1.15 Billion USD | 7.23% |
| 2010 Q4 | 313.35 Million USD | 5.99% |
| 2010 Q3 | 295.63 Million USD | 2.2% |
| 2010 Q2 | 289.27 Million USD | 11.15% |
| 2010 Q1 | 260.25 Million USD | -8.18% |
| 2009 Q4 | 283.45 Million USD | -0.62% |
| 2009 Q1 | 251.14 Million USD | -6.57% |
| 2009 Q3 | 285.23 Million USD | 9.45% |
| 2009 FY | 1.08 Billion USD | 1.62% |
| 2009 Q2 | 260.59 Million USD | 3.76% |
| 2008 Q3 | 285.88 Million USD | 8.52% |
| 2008 Q4 | 268.8 Million USD | -5.97% |
| 2008 Q1 | 245.03 Million USD | -3.46% |
| 2008 Q2 | 263.45 Million USD | 7.52% |
| 2008 FY | 1.06 Billion USD | 11.84% |
| 2007 Q2 | 225.53 Million USD | 2.79% |
| 2007 FY | 950.64 Million USD | 10.67% |
| 2007 Q4 | 253.82 Million USD | 0.78% |
| 2007 Q3 | 251.86 Million USD | 11.67% |
| 2007 Q1 | 219.42 Million USD | 1.57% |
| 2006 Q3 | 225.79 Million USD | 6.81% |
| 2006 Q1 | 205.73 Million USD | -6.83% |
| 2006 FY | 858.96 Million USD | 6.49% |
| 2006 Q4 | 216.02 Million USD | -4.33% |
| 2006 Q2 | 211.39 Million USD | 2.75% |
| 2005 Q1 | 147.89 Million USD | 13.06% |
| 2005 Q3 | 222.14 Million USD | 2.95% |
| 2005 FY | 806.61 Million USD | 64.56% |
| 2005 Q2 | 215.77 Million USD | 45.9% |
| 2005 Q4 | 220.81 Million USD | -0.6% |
| 2004 Q4 | 130.81 Million USD | 1.34% |
| 2004 Q2 | 120.55 Million USD | 9.86% |
| 2004 Q1 | 109.73 Million USD | -2.86% |
| 2004 FY | 490.17 Million USD | 19.04% |
| 2004 Q3 | 129.07 Million USD | 7.07% |
| 2003 Q1 | 94.01 Million USD | -0.75% |
| 2003 FY | 411.79 Million USD | 30.6% |
| 2003 Q3 | 108.44 Million USD | 12.53% |
| 2003 Q2 | 96.36 Million USD | 2.5% |
| 2003 Q4 | 112.96 Million USD | 4.17% |
| 2002 Q1 | 58.11 Million USD | -16.61% |
| 2002 Q2 | 71.91 Million USD | 23.74% |
| 2002 Q4 | 94.72 Million USD | 4.59% |
| 2002 FY | 315.3 Million USD | 34.42% |
| 2002 Q3 | 90.56 Million USD | 25.94% |
| 2001 Q2 | 56.02 Million USD | 14.58% |
| 2001 Q3 | 59.96 Million USD | 7.02% |
| 2001 Q4 | 69.68 Million USD | 16.22% |
| 2001 FY | 234.57 Million USD | 18.88% |
| 2001 Q1 | 48.89 Million USD | -11.47% |
| 2000 Q3 | 50.9 Million USD | 0.27% |
| 2000 Q4 | 55.23 Million USD | 8.5% |
| 2000 Q1 | 40.4 Million USD | -10.62% |
| 2000 FY | 197.31 Million USD | 19.37% |
| 2000 Q2 | 50.76 Million USD | 25.67% |
| 1999 Q3 | 43.4 Million USD | 4.08% |
| 1999 FY | 165.3 Million USD | 12.3% |
| 1999 Q2 | 41.7 Million USD | 19.14% |
| 1999 Q1 | 35 Million USD | 2287.5% |
| 1999 Q4 | 45.2 Million USD | 4.15% |
| 1998 Q1 | 42.8 Million USD | 5.68% |
| 1998 Q3 | 54.2 Million USD | 4.63% |
| 1998 Q4 | -1.6 Million USD | -102.95% |
| 1998 FY | 147.2 Million USD | 4.03% |
| 1998 Q2 | 51.8 Million USD | 21.03% |
| 1997 Q2 | 33.7 Million USD | 18.66% |
| 1997 Q1 | 28.4 Million USD | -8.97% |
| 1997 Q4 | 40.5 Million USD | 4.11% |
| 1997 FY | 141.5 Million USD | 29.7% |
| 1997 Q3 | 38.9 Million USD | 15.43% |
| 1996 Q4 | 31.2 Million USD | 7.96% |
| 1996 Q2 | 26.8 Million USD | 20.72% |
| 1996 Q1 | 22.2 Million USD | -10.48% |
| 1996 FY | 109.1 Million USD | 12.36% |
| 1996 Q3 | 28.9 Million USD | 7.84% |
| 1995 FY | 97.1 Million USD | 1.57% |
| 1995 Q4 | 24.8 Million USD | -1.59% |
| 1995 Q3 | 25.2 Million USD | 5.88% |
| 1995 Q1 | 23.2 Million USD | -4.53% |
| 1995 Q2 | 23.8 Million USD | 2.59% |
| 1994 Q2 | 24.5 Million USD | 6.99% |
| 1994 Q4 | 24.3 Million USD | 1.67% |
| 1994 Q3 | 23.9 Million USD | -2.45% |
| 1994 Q1 | 22.9 Million USD | 3.15% |
| 1994 FY | 95.6 Million USD | 3.13% |
| 1993 FY | 92.7 Million USD | 46.45% |
| 1993 Q1 | 22.4 Million USD | 2.28% |
| 1993 Q2 | 23.7 Million USD | 5.8% |
| 1993 Q3 | 24.5 Million USD | 3.38% |
| 1993 Q4 | 22.2 Million USD | -9.39% |
| 1992 Q4 | 21.9 Million USD | 13.47% |
| 1992 Q1 | 10.7 Million USD | 4.9% |
| 1992 FY | 63.3 Million USD | 78.31% |
| 1992 Q2 | 11.3 Million USD | 5.61% |
| 1992 Q3 | 19.3 Million USD | 70.8% |
| 1991 Q3 | 9 Million USD | 0.0% |
| 1991 Q1 | 7.3 Million USD | -45.11% |
| 1991 Q2 | 9 Million USD | 23.29% |
| 1991 Q4 | 10.2 Million USD | 13.33% |
| 1991 FY | 35.5 Million USD | -26.35% |
| 1990 Q2 | 13.2 Million USD | 28.16% |
| 1990 Q4 | 13.3 Million USD | 15.65% |
| 1990 Q1 | 10.3 Million USD | -23.13% |
| 1990 FY | 48.2 Million USD | -8.71% |
| 1990 Q3 | 11.5 Million USD | -12.88% |
| 1989 Q1 | 14.3 Million USD | -91.07% |
| 1989 FY | 52.8 Million USD | -91.36% |
| 1989 Q3 | 10.7 Million USD | -25.69% |
| 1989 Q4 | 13.4 Million USD | 25.23% |
| 1989 Q2 | 14.4 Million USD | 0.7% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -3618.398% |
| AngioDynamics, Inc. | 303.91 Million USD | -1082.308% |
| AtriCure, Inc. | 399.24 Million USD | -799.999% |
| Avinger, Inc. | 7.65 Million USD | -46857.658% |
| Azenta, Inc. | 665.07 Million USD | -440.272% |
| BioLife Solutions, Inc. | 143.27 Million USD | -2407.974% |
| Daxor Corporation | 1.28 Million USD | -280505.85% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -19557.53% |
| Femasys Inc. | 1.07 Million USD | -335095.948% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | -3101.069% |
| Hologic, Inc. | 4.03 Billion USD | 10.845% |
| ICU Medical, Inc. | 2.25 Billion USD | -59.053% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 49.563% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -12499.909% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | -1757.104% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -311680.084% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -311680.084% |
| Masimo Corporation | 2.04 Billion USD | -75.441% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -3600.556% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | -185.772% |
| Nephros, Inc. | 14.23 Million USD | -25136.691% |
| NovoCure Limited | 509.33 Million USD | -605.465% |
| NEXGEL, Inc. | 4.08 Million USD | -87774.786% |
| NEXGEL, Inc. | 4.08 Million USD | -87774.786% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -123335.246% |
| OraSure Technologies, Inc. | 405.47 Million USD | -786.177% |
| Pro-Dex, Inc. | 53.84 Million USD | -6573.353% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -201754.622% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -18708.282% |
| QuidelOrtho Corporation | 2.99 Billion USD | -19.861% |
| Repligen Corporation | 638.76 Million USD | -462.524% |
| Sanara MedTech Inc. | 64.98 Million USD | -5428.864% |
| STAAR Surgical Company | 322.41 Million USD | -1014.464% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -7054.349% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 9.377% |
| Jin Medical International Ltd. | 19.82 Million USD | -18027.83% |